A Novel Ultrasound Probe for Thyroid Imaging and Machine Learning (THYMAL 01)

April 3, 2026 updated by: Sound Blade Medical Inc.

A Novel Ultrasound Probe for Thyroid Imaging and Machine Learning: A Pilot Study

The objective of the THYMAL 01 pilot study is to evaluate the Sound Blade Imaging System in subjects with benign thyroid nodules undergoing standard-of-care ultrasound imaging.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Our purpose-built thyroid US platform, integrated with state-of-the-art machine-learning algorithms, will achieve accurate detection and delineation of thyroid nodules and neighboring critical structures, and will produce a trackable three-dimensional nodule model capable of guiding minimally invasive ablation while providing real-time volumetric quantification of treatment progress and residual disease.

STUDY DESIGN This study will consist of two parts. Part A - Prospective Thyroid Imaging Study We will conduct a prospective, paired imaging study (n=30) to determine whether the study US device acquires results/ability to detect thyroid nodules and key structures (common carotid artery, internal jugular vein, trachea, vagus nerve, recurrent laryngeal nerve, and parathyroid glands) that are comparable to the standard-of-care (SOC) US device.

Part B - Machine Learning Model Development US images and cine video acquired from the investigational device and radiologist annotations from Part A will be used to train and internally test an ML model for nodule and critical-structure segmentation. For external validation the ML model will be applied to anonymized thyroid US studies acquired on the standard-of-care (SOC) US and retrieved retrospectively from the provincial PACS (n≈30). Accuracy and precision will be assessed to establish technical validity and generalizability. ML outputs are for research only; no clinical decisions will be based on them.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Richard Balys, MD, MD
  • Phone Number: 902-223-8032
  • Email: rbalys@gmail.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Participants must be ≥ 18 years of age
  • Able and willing to sign informed consent
  • Known thyroid nodule demonstrated on a prior thyroid US and is undergoing active surveillance of the nodule with serial USs

Exclusion Criteria:

  • Unable to lay flat for 15 minutes
  • Active neck wounds, dressings, or skin conditions that would interfere with neck US (e.g., preclude transducer placement)
  • Cervical spine or back disease that would prevent neck extension and would hinder the ability to obtain accurate thyroid US images
  • Previous thyroid surgeries, radiation of face and neck
  • Known inflammatory thyroid diseases or thyroiditis (e.g., Graves, Hashimoto)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Thyroid Ultrasound
Patients who are scheduled for a SOC surveillance Thyroid Nodule Ultrasound will undergo a second ultrasound using the Sound Blade Ultrasound.
Patients who are scheduled for a SOC surveillance Thyroid Nodule Ultrasound will undergo a second ultrasound using the Sound Blade Ultrasound.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Ability to Visualization Thyroid Nodules and other key Anatomical Structures
Time Frame: Day 1
The primary endpoint is to evaluate the ability to visualize thyroid nodules and other key anatomical structures with the investigational device compared to the SOC US imaging device.
Day 1
Evaluate the visibility/detection performance of a machine-learning model
Time Frame: Day 1
A machine-learning model will be created to identify and segment thyroid nodules and key anatomical neck structures. The first outcome will evaluate performance of visibility and detection using standard classification measures
Day 1
Evaluate the segmentation performance of a machine-learning model
Time Frame: Day 1
A machine-learning model will be created to identify and segment thyroid nodules and key anatomical neck structures. The second outcome will evaluate performance on delineable cases.
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Richard Bayls, MD, Nova Scotia Health Authority

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 31, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

September 1, 2027

Study Registration Dates

First Submitted

February 27, 2026

First Submitted That Met QC Criteria

March 18, 2026

First Posted (Actual)

March 23, 2026

Study Record Updates

Last Update Posted (Actual)

April 7, 2026

Last Update Submitted That Met QC Criteria

April 3, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This is an internal feasibility study at this point.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thyroid Nodules

Clinical Trials on Thyroid ultrasound

Subscribe